Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 03, 2019

Safety and Effectiveness of Oral Propranolol in Patients With VHL Disease and Retinal Hemangioblastomas

BMJ Open Ophthalmology


Additional Info

Disclosure statements are available on the authors' profiles:

BMJ Open Ophthalmology
Evaluation of the Safety and Effectiveness of Oral Propranolol in Patients With Von Hippel-Lindau Disease and Retinal Hemangioblastomas: Phase III Clinical Trial
BMJ Open Ophthalmol 2019 May 28;[EPub Ahead of Print], B González-Rodríguez, K Villar Gómez de Las Heras, DT Aguirre, L Rodríguez-Padial, V Albiñana, L Recio-Poveda, AM Cuesta, LM Botella, RM Jiménez-Escribano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading